MBCL-30. SUBGROUP-DIRECTED CLINICAL AND MOLECULAR STRATIFICATION OF DISEASE RISK IN INFANT MEDULLOBLASTOMA

Understanding the specific molecular pathology of infant medulloblastoma (iMB) is urgently required to inform contemporary treatments, risk-stratification and clinical trials. Comprehensive analysis incorporating central clinical/ pathological review and molecular subgroup, copy number aberration an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Hicks, Debbie, Rafiee, Gholamreza, Schwalbe, Edward C, Lindsey, Janet C, Hill, Rebecca M, Smith, Amanda, Crosier, Stephen, Joshi, Abhijit, Robson, Keith, Wharton, Stephen, Jacques, Thomas, Williamson, Daniel, Bailey, Simon, Clifford, Steven C
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.426
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados